Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting

BACKGROUND: Non-nucleoside reverse transcriptase inhibitor (NNRTI) with stavudine and lamivudine is widely used as the first-line antiretroviral therapy (ART) in resource-limited settings. Lipodystrophy is common and options for switching ART regimen are limited; this situation can lead to patients&...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sungkanuparph, Somnuek, Kiertiburanakul, Sasisopin, Apisarnthanarak, Anucha, Malathum, Kumthorn, Watcharananan, Siriorn, Sathapatayavongs, Boonmee
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2007
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2211500/
https://ncbi.nlm.nih.gov/pubmed/18031583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-4-26
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky